| scholarly article | Q13442814 |
| P50 | author | Thomas G Moens | Q57161565 |
| Damian M Cummings | Q64663855 | ||
| Kenneth J Smith | Q79389693 | ||
| Muzammil A Nahaboo Solim | Q86597868 | ||
| P2093 | author name string | John Hardy | |
| Mar Matarin | |||
| Jill C Richardson | |||
| Dervis A Salih | |||
| Frances A Edwards | |||
| Marina Yasvoina | |||
| Shabinah S Ali | |||
| Wenfei Liu | |||
| Sebastian Guelfi | |||
| Judy Latcham | |||
| Marina Perona | |||
| Roshni Desai | |||
| Michael Fulleylove | |||
| Rocio Moreno Paublete | |||
| P2860 | cites work | TREM2 Variants in Alzheimer's Disease | Q22250873 |
| Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 | ||
| Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease | Q27309046 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid | Q28207898 | ||
| Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
| Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly | Q28587858 | ||
| Explaining human uniqueness: genome interactions with environment, behaviour and culture | Q28750822 | ||
| A general framework for weighted gene co-expression network analysis | Q29617580 | ||
| Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies | Q30485119 | ||
| Gene network interconnectedness and the generalized topological overlap measure | Q33270231 | ||
| TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice | Q33343490 | ||
| Strategies for aggregating gene expression data: the collapseRows R function | Q33981973 | ||
| C1q and its growing family. | Q34633739 | ||
| Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. | Q34714933 | ||
| Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target | Q35127284 | ||
| Conservation and evolution of gene coexpression networks in human and chimpanzee brains | Q35215128 | ||
| Controlled Cortical Impact and Craniotomy Induce Strikingly Similar Profiles of Inflammatory Gene Expression, but with Distinct Kinetics | Q36357705 | ||
| Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques | Q36592191 | ||
| Alzheimer's disease genetics: lessons to improve disease modelling | Q37905128 | ||
| The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease | Q41573050 | ||
| Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. | Q44872334 | ||
| Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease | Q46519969 | ||
| Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease | Q47406803 | ||
| Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model | Q48251682 | ||
| Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. | Q48267298 | ||
| Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. | Q48499999 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microtubule associated protein tau | Q419507 |
| Amyloid beta precursor protein | Q423510 | ||
| database | Q8513 | ||
| pathology | Q7208 | ||
| P304 | page(s) | 633-644 | |
| P577 | publication date | 2015-01-22 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology | |
| P478 | volume | 10 |
| Q57740664 | A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease |
| Q90263988 | Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease |
| Q90351471 | Alzheimer Disease: An Update on Pathobiology and Treatment Strategies |
| Q30251865 | Alzheimer's disease |
| Q61801150 | Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph |
| Q48231165 | Alzheimer's disease: where next for anti-amyloid therapies? |
| Q39136356 | Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model. |
| Q91877796 | Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease |
| Q41687578 | BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology |
| Q37462091 | Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster |
| Q52690916 | Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration. |
| Q93242707 | CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum |
| Q52317581 | CXCR4 involvement in neurodegenerative diseases |
| Q48703268 | Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ. |
| Q47105056 | Comparative profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation |
| Q91585548 | Complement C7 is a novel risk gene for Alzheimer's disease in Han Chinese |
| Q90568409 | Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice |
| Q50531818 | Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models |
| Q36066679 | First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression |
| Q98177882 | Galectin-3 Secreted by Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Reduces Aberrant Tau Phosphorylation in an Alzheimer Disease Model |
| Q26785375 | Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease |
| Q90581532 | Genetic association of the cytochrome c oxidase-related genes with Alzheimer's disease in Han Chinese |
| Q91796279 | Genetic variability in response to amyloid beta deposition influences Alzheimer's disease risk |
| Q58697755 | Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis |
| Q47124444 | Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish |
| Q63988407 | Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia |
| Q36280558 | Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis |
| Q36454535 | Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease |
| Q64899746 | Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer's Disease Pathology and Shows Differential Expression in Transgenic Mice. |
| Q60045126 | Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP |
| Q91660737 | Intersection of pathological tau and microglia at the synapse |
| Q94452107 | Investigating APOE, APP-Aβ metabolism genes and Alzheimer's disease GWAS hits in brain small vessel ischemic disease |
| Q64061523 | LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer's disease brains |
| Q89509439 | Lemur Tyrosine Kinase 2 (LMTK2) Level Inversely Correlates with Phospho-Tau in Neuropathological Stages of Alzheimer's Disease |
| Q58778218 | Loss of Trem2 in microglia leads to widespread disruption of cell coexpression networks in mouse brain |
| Q30275974 | Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease? |
| Q41848600 | Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging |
| Q87845843 | Membrane damage is at the core of Alzheimer's disease |
| Q51762755 | Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3. |
| Q42038294 | Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease. |
| Q46046188 | Microglial repopulation resolves inflammation and promotes brain recovery after injury. |
| Q41328860 | Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology. |
| Q34555880 | NMNAT: It's an NAD+ synthase… It's a chaperone… It's a neuroprotector. |
| Q48235737 | Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease. |
| Q47259208 | Neuroinflammatory responses in Alzheimer's disease |
| Q48249743 | Neuronal and Peripheral Pentraxins Modify Glutamate Release and may Interact in Blood-Brain Barrier Failure. |
| Q48497433 | Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model |
| Q92725736 | Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology |
| Q58605610 | PA28αβ overexpression enhances learning and memory of female mice without inducing 20S proteasome activity |
| Q89574799 | PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2 |
| Q47216715 | Phagocytic Roles of Glial Cells in Healthy and Diseased Brains |
| Q38670400 | Polygenic risk score analysis of pathologically confirmed Alzheimer disease |
| Q58027500 | Rodent models for Alzheimer disease |
| Q91705233 | Selective vulnerability in neurodegenerative diseases |
| Q93134029 | Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression |
| Q59410002 | Susceptibility of brain atrophy to in Alzheimer's disease, evidence from functional prioritization in imaging genetics |
| Q91173649 | TIP60/KAT5 is required for neuronal viability in hippocampal CA1 |
| Q42736886 | TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy |
| Q38646212 | TREM2 in Neurodegenerative Diseases |
| Q36144523 | The Challenge of Stability in High-Throughput Gene Expression Analysis: Comprehensive Selection and Evaluation of Reference Genes for BALB/c Mice Spleen Samples in the Leishmania infantum Infection Model. |
| Q64981048 | The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease. |
| Q26749528 | The amyloid hypothesis of Alzheimer's disease at 25 years |
| Q46342780 | The diphenylpyrazole compound anle138b blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology. |
| Q89948704 | The multiplex model of the genetics of Alzheimer's disease |
| Q37054759 | The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer's disease |
| Q89673969 | Transcriptional Signatures of Tau and Amyloid Neuropathology |
| Q61445380 | Transcriptomic immaturity inducible by neural hyperexcitation is shared by multiple neuropsychiatric disorders |
| Q47135162 | Triggering Receptor Expressed on Myeloid Cells 2 Overexpression Inhibits Proinflammatory Cytokines in Lipopolysaccharide-Stimulated Microglia |
| Q91185200 | Variation among intact tissue samples reveals the core transcriptional features of human CNS cell classes |
| Q92698961 | Wnt Signaling Deregulation in the Aging and Alzheimer's Brain |
| Q35945633 | sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers |
Search more.